Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.

Vasoactive intestinal peptide (VIP) is an anti-inflammatory immunomodulatory neuropeptide with therapeutic potential demonstrated for collagen-induced arthritis. The aim of this study was to characterise its potential anti-arthritic effect on human monocytes, macrophages, T cells, and rheumatoid art...

Descrizione completa

Dettagli Bibliografici
Autori principali: Foey, A, Field, S, Ahmed, S, Jain, A, Feldmann, M, Brennan, F, Williams, R
Natura: Journal article
Lingua:English
Pubblicazione: BioMed Central 2003